Updated at 2 p.m.
WASHINGTON — Anthem’s $54 billion merger deal with Cigna is considered to be on life support after a federal appeals court ruled last week it violated antitrust law. But on Friday, Anthem said it is appealing that decision to the U.S. Supreme Court. Continue Reading →
WASHINGTON — Anthem and the Justice Department faced off in court Friday over the insurer’s proposed merger with Cigna, with the legal wrangling centered on whether any savings from the deal would justify shrinking the market for large employer insurance policies from four to three carriers. Continue Reading →
WASHINGTON — The messy divorce between Anthem and Cigna took another turn Wednesday in a Delaware court that will be the scene of further expensive legal battling over the insurers’ merger attempt. Continue Reading →
WASHINGTON — The tumultuous relationship between proposed merger partners Anthem and Cigna continued Tuesday as Cigna called for an end to the deal and demanded about $15 billion from Anthem – which said it is “committed to closing the transaction.” Continue Reading →
WASHINGTON — After a federal judge blocked the deal last month, Aetna on Tuesday announced it would no longer pursue a $37 billion merger with Humana. U.S. District Judge John Bates ruled last month that a merger of the health insurers would result in a lack of competition in the Medicare Advantage market.
Continue Reading →
WASHINGTON — Anthem said Thursday it will appeal a federal court’s decision to block the health insurer’s planned merger with Cigna. The decision to appeal came quickly on the heels of U.S. District Judge Amy Berman Jackson’s ruling late Wednesday that the $54 billion merger would reduce competition in dozens of insurance markets across the nation. Continue Reading →
Updated at 4:35 p.m.
WASHINGTON — A federal judge on Monday rejected a proposed merger between Aetna and Humana, saying the $37 billion deal would “be likely to substantially lessen competition” in the Medicare Advantage market. Aetna is considering an appeal. Continue Reading →
WASHINGTON — The antitrust trial over a proposed merger between Aetna and Humana wrapped up Wednesday, with U.S. District Court Judge John Bates asking probing questions of both Justice Department lawyers seeking to block the deal and attorneys for the insurers defending their plan. Continue Reading →
WASHINGTON — Hostilities between proposed merger partners Anthem and Cigna were on full display Tuesday at a key point of a U.S. antitrust trial over the deal. Cigna attorney Rick Rule said the company did not sign a key closing document because it did not agree with Anthem’s characterizations of the testimony of certain Cigna witnesses. Continue Reading →
Updated at 4:57 p.m.
WASHINGTON — Opening salvos were fired Monday in the antitrust case against the proposed merger of Aetna and Humana, with Justice Department attorneys arguing the tie-up would mean sharp price hikes for Medicare Advantage plans and a disintegration of choice for people purchasing insurance on Affordable Care Act exchanges. Continue Reading →
WASHINGTON – As the first part of the antitrust trial on a proposed merger of Anthem and Cigna is wrapping up, a similar challenge to Aetna’s plan to merge with Humana will begin Monday. While both are the result of lawsuits to block the mergers filed by the Justice Department on the same day in July, the trials will be much different. Continue Reading →
WASHINGTON — Anthem, Cigna and the U.S. Justice Department on Monday tried to sway a federal judge with widely differing views on the impact a proposed merger of the insurers would have on the U.S. health care market. Continue Reading →
WASHINGTON – UnitedHealthcare, the nation’s largest health insurer and former potential suitor to merge with Cigna, provided the Justice Department with a large amount of sensitive, proprietary and confidential information to help the government investigate and block the mergers by its rivals. Continue Reading →
WASHINGTON — In its court battle to block the merger of Anthem and Cigna, the U.S. Justice Department plans to use Connecticut’s market as a prime example of why increased consolidation in the health insurance field would hurt consumers. “It was clear to us… that if Connecticut had not decided to participate in the lawsuit, (the state) would have been a focal point of the case anyhow,” said Connecticut Attorney General George Jepsen, who has joined the DOJ lawsuit. Continue Reading →
WASHINGTON – Sen. Richard Blumenthal on Tuesday asked the Federal Trade Commission to investigate whether EpiPen manufacturer Mylan broke anti-trust laws when it gave away or sold its product at discounted prices to schools. Continue Reading →